Recommendations for cervical cancer prevention in Asia Pacific (Q37306174)

19 August 2017

title

Recommendations for cervical cancer prevention in Asia Pacific (English)

1 reference

19 August 2017

main subject

cervix uterine cancer

1 reference

You-Lin Qiao

8

0 references

Sue Goldie

4

Sue J Goldie

1 reference

19 August 2017

Suzanne Marie Garland

1

Suzanne M Garland

1 reference

Rengaswamy Sankaranarayanan

19 August 2017

9

Rengaswamy Sankaranarayanan

1 reference

19 August 2017

2

Jack Cuzick

1 reference

Francesc Xavier Bosch José

19 August 2017

12

F Xavier Bosch

1 reference

19 August 2017

Efren J Domingo

3

1 reference

19 August 2017

Young-Tak Kim

5

1 reference

19 August 2017

Ryo Konno

6

1 reference

19 August 2017

D Maxwell Parkin

7

1 reference

19 August 2017

Peter L Stern

10

1 reference

19 August 2017

Sun Kuie Tay

11

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

26 Suppl 12

1 reference

19 August 2017

page(s)

M89-98

1 reference

Human papillomavirus infection and cervical cancer prevention in Japan and Korea

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Prevalence of human papillomavirus infection in women in Busan, South Korea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Acquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: a follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Estimates for cervical abnormalities in Vanuatu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Randomised controlled trial of an educational strategy to increase school-based adolescent hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Challenges to accepting a human papilloma virus (HPV) vaccine: a qualitative study of Australian women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Knowledge and awareness of human papillomavirus (HPV): attitudes towards HPV vaccination among a representative sample of women in Victoria, Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

The promise of global cervical-cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Introduction of human papillomavirus vaccines into developing countries - international strategies for funding and procurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Mathematical models of cervical cancer prevention in the Asia Pacific region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Mathematical models of cervical cancer prevention in Latin America and the Caribbean

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Modeling cervical cancer prevention in developed countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

Human papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.06.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.06.020

1 reference

19 August 2017

1 reference